Citalopram in children and adolescents with depression or anxiety

Annals of Pharmacotherapy

Volumn 36, Issue 11, 2002, Pages 1692-1697

  Baumgartner, Jennifer L ^a,b,c   Emslie, Graham J ^d   Crismon, M Lynn ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Department of Mental Health and Mental Retardation ^*  (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Citalopram; Pediatrics

Indexed keywords

AMITRIPTYLINE; AMPHETAMINE; CITALOPRAM; CROMOGLYCATE DISODIUM; LITHIUM; METHYLPHENIDATE; OLANZAPINE; SALBUTAMOL; TRAZODONE; VALPROIC ACID;

ADOLESCENT; ANXIETY DISORDER; APPETITE DISORDER; ARTICLE; CHILD PSYCHIATRY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; LIBIDO DISORDER; MALE; NAUSEA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHOOL CHILD; SCORING SYSTEM; TREATMENT OUTCOME; TREMOR; XEROSTOMIA;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; CHILD; CITALOPRAM; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036841813     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C078     Document Type: Article

References (35)

1. Fleming JE, Offord DR. Epidemiology of childhood depressive disorders: A critical review. J Am Acad Child Adolesc Psychiatry 1990;29: 571-80.
2. Lewinsohn PM, Hops H, Roberts RE, Seeley JR, Andrews JA. Adolescent psychopathology I: Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 1993;102:133-44.
3. Skaer TL, Robison LM, Sclar DA, Galin RS. Treatment of depressive illness among children and adolescents in the United States. Curr Ther Res Clin Exp 2000;61:692-705.
4. Bowen RC, Offord DR, Boyle MH. The prevalence of over-anxious disorder and separation anxiety: Results from the Ontario child health study. J Am Acad Child Adolesc Psychiatry 1990;29:753-8.
5. Whitaker A, Johnson J, Shaffer D, Rapoport JL, Kalikow K, Walsh BT, et al. Uncommon troubles in young people: Prevalence estimates of selected psychiatric disorders in a nonreferred adolescent population. Arch Gen Psychiatry 1990;47:487-96.
6. Hoar W. Prozac Rx for children jumps 500%. Ment Health News Alert, 1998, September 29:13.
7. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:1031-7.
8. Keller MB, Ryan ND, Strober M, Klein RG. Kutcher SP, Birmaher B, et al. Efficacy of paroxetine in the treatment of adolescent major depression, a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762-72.
9. Product Information. Celexa (Citalopram Hydrobromide). St. Louis: Forest Laboratories, December 2000.
10. Hyttel J. Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 1982;6:277-95.
11. Feighner JP, Overo K. Multicenter. Placebo-controlled, fixed- dose study of citalopram in moderate-to-severe depression. J Clin Psychiatry 1999; 60:824-30.
12. Mendels J, Kiev A, Fabre LF. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia. Depression Anxiety 1999;9:54-60.
13. Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K. The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 1987;41:266-74.
14. Naranjo CA, Poulos CX, Bremner KE, Lanctot KL. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol- dependent drinkers. Clin Pharmacol Ther 1992;51:729-39.
15. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. Br J Psychiatry 1990; 157:894-901.
16. Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M, et al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 1992;86:138-45.
17. Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992;52:547-52.
18. Koponen H, Lepola H, Leinonen E. Citalopram in the treatment of obsessive-compulsive disorder: A report of 2 cases. Eur Psychiatry 1997; 10:209-10.
19. Montgomery SA, Kasper S, Stein DJ, Bang Hedegaard K, Lemming OM. Citalopram 20mg, 40mg, 60mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. Int Clin Psychopharmacol 2001;16:75-86.
20. Mundo E, Blanchi L, Bellodi L. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: A single-blind study. J Clin Psychopharmacol 1997;17:267-71.
21. Stein DJ, Maud CM, Bouwer C. Use of the serotonin selective reuptake inhibitor citalopram in obsessive-compulsive disorder. J Serotonin Res 1996;3:29-33.
22. Humble M, Wistedt B. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders. Int Clin Psychopharmacol 1992;5:21-39.
23. Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjodin I, et al. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. J Clin Psychiatry 1998;59:528-34.
24. Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T. The effect of citalopram in panic disorder. Br J Psychiatry 1997;170:549-53.
25. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson F, et al. Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 1998; 18:390-8.
26. Stein DJ, Bouwer C, Maud CM. Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania. Eur Arch Psychiatry Clin Neurosci 1997;247:234-6.
27. Bajo S, Battaglia M, Pegna C, Bellodi L. Citalopram and fluvoxamine in Tourette’s disorder. J Am Acad Child Adolesc Psychiatry 1999;38:230-1.
28. Thomsen PH, Mikkelsen HU. Course of obsessive-compulsive disorder in children and adolescents: A prospective follow-up study of 23 Danish cases. J Am Acad Child Adolesc Psychiatry 1995;34:1432-40.
29. Thomsen PH. Child and adolescent obsessive-compulsive disorder treated with citalopram: Findings from an open trial of 23 cases. J Child Adolesc Psychopharmacol 1997;7:157-66.
30. Lepola U, Leinonen E, Koponen H. Citalopram in the treatment of early-onset panic disorder and school phobia. Pharmacopsychiatry 1996;29: 30-2.
31. Bostic JQ, Prince J, Brown K, Place S. A retrospective study of citalopram in adolescents with depression. J Child Adolesc Psychopharmacol 2001;11:159-66.
32. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington, DC: American Psychiatric Association, 1994.
33. Biggs MM, Shores-Wilson K, Rush AJ, Carmody TJ, Trivedi MH, Crismon ML, et al. A comparison of alternative assessments of depressive symptom severity: A pilot study. Psychiatry Res 2000;96:269-79.
34. Jain U, Birmaher B, Garcia M, Al-Shabbout M, Ryan N. Fluoxetine in children and adolescents with mood disorders: A chart review of efficacy and adverse effects. J Child Adolesc Psychopharmacol 1992;2:259-65.
35. Tierney E, Joshi PT, Llinas JF, Rosenberg LA, Riddle MA. Sertraline for major depression in children and adolescents: Preliminary clinical experience. J Child Adolesc Psychopharmacol 1995;5:13-27.